• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉丁美洲地区 HIV 感染成年人严重非艾滋病事件分析。

Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites.

机构信息

Hospital Italiano and CICAL, Buenos Aires, Argentina.

出版信息

HIV Med. 2010 Oct 1;11(9):554-64. doi: 10.1111/j.1468-1293.2010.00824.x. Epub 2010 Mar 21.

DOI:10.1111/j.1468-1293.2010.00824.x
PMID:20345879
Abstract

OBJECTIVE

Acquired immune deficiency appears to be associated with serious non-AIDS (SNA)-defining conditions such as cardiovascular disease, liver and renal insufficiency and non-AIDS-related malignancies. We analysed the incidence of, and factors associated with, several SNA events in the LATINA retrospective cohort.

MATERIALS AND METHODS

Cases of SNA events were recorded among cohort patients. Three controls were selected for each case from cohort members at risk. Conditional logistic models were fitted to estimate the effect of traditional risk factors as well as HIV-associated factors on non-AIDS-defining conditions.

RESULTS

Among 6007 patients in follow-up, 130 had an SNA event (0.86 events/100 person-years of follow-up) and were defined as cases (40 with cardiovascular events, 54 with serious liver failure, 35 with non-AIDS-defining malignancies and two with renal insufficiency). Risk factors such as diabetes, hepatitis B and C virus coinfections and alcohol abuse showed an association with events, as expected. The last recorded CD4 T-cell count prior to index date (P = 0.0056, with an average difference of more than 100 cells/μL) and area under the CD4 cell curve in the year previous to index date (P = 0.0081) were significantly lower in cases than in controls. CD4 cell count at index date was significantly associated with the outcome after adjusting for risk factors.

CONCLUSIONS

The incidence and type of SNA events found in this Latin American cohort are similar to those reported in other regions. We found a significant association between immune deficiency and the risk of SNA events, even in patients under antiretroviral treatment.

摘要

目的

获得性免疫缺陷似乎与严重的非艾滋病(SNA)定义疾病相关,如心血管疾病、肝肾功能不全和非艾滋病相关恶性肿瘤。我们分析了 LATINA 回顾性队列中几种 SNA 事件的发生率和相关因素。

材料和方法

记录队列患者的 SNA 事件病例。从有风险的队列成员中为每个病例选择 3 名对照。采用条件逻辑模型估计传统危险因素以及与 HIV 相关的因素对非艾滋病定义疾病的影响。

结果

在随访的 6007 名患者中,有 130 名发生 SNA 事件(0.86 例/100 人年),并被定义为病例(40 例心血管事件、54 例严重肝功能衰竭、35 例非艾滋病定义的恶性肿瘤和 2 例肾功能不全)。糖尿病、乙型和丙型肝炎病毒合并感染以及酗酒等危险因素与预期的事件相关。在索引日期之前的最后一次记录的 CD4 T 细胞计数(P = 0.0056,平均差异超过 100 个细胞/μL)和索引日期前一年的 CD4 细胞曲线下面积(P = 0.0081)明显低于对照组。在调整危险因素后,CD4 细胞计数与结局显著相关。

结论

在本拉丁美洲队列中发现的 SNA 事件的发生率和类型与其他地区报告的相似。我们发现免疫缺陷与 SNA 事件风险之间存在显著关联,即使在接受抗逆转录病毒治疗的患者中也是如此。

相似文献

1
Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites.拉丁美洲地区 HIV 感染成年人严重非艾滋病事件分析。
HIV Med. 2010 Oct 1;11(9):554-64. doi: 10.1111/j.1468-1293.2010.00824.x. Epub 2010 Mar 21.
2
Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.尚未接受抗逆转录病毒治疗的HIV感染患者发生非艾滋病定义事件的风险。
HIV Med. 2015 May;16(5):265-72. doi: 10.1111/hiv.12202. Epub 2015 Jan 21.
3
Risk of cancers during interrupted antiretroviral therapy in the SMART study.SMART研究中中断抗逆转录病毒治疗期间的癌症风险。
AIDS. 2007 Sep 12;21(14):1957-63. doi: 10.1097/QAD.0b013e3282ed6338.
4
[Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].[一组智利患者中人类免疫缺陷病毒感染的自然史]
Rev Med Chil. 1996 May;124(5):525-35.
5
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.1994-2007 年美国患者的艾滋病定义性机会性感染疾病:一项队列研究。
AIDS. 2010 Jun 19;24(10):1549-59. doi: 10.1097/QAD.0b013e32833a3967.
6
The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.已停止机会性感染预防的免疫重建的HIV感染儿童中严重细菌感染的发生率。
Pediatrics. 2005 Apr;115(4):e488-94. doi: 10.1542/peds.2004-1847. Epub 2005 Mar 16.
7
Human immunodeficiency virus in an aging population, a complication of success.老龄化人口中的人类免疫缺陷病毒,成功的并发症。
J Am Geriatr Soc. 2009 Nov;57(11):2129-38. doi: 10.1111/j.1532-5415.2009.02494.x. Epub 2009 Sep 28.
8
AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.艾滋病界定性和非艾滋病界定性恶性肿瘤:抗逆转录病毒治疗时代的癌症发生情况
Curr Opin Oncol. 2007 Sep;19(5):446-51. doi: 10.1097/CCO.0b013e3282c8c90d.
9
Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.1989 - 2002年HIV感染患者中艾滋病界定性和非艾滋病界定性恶性肿瘤的发病趋势
Clin Infect Dis. 2004 Nov 1;39(9):1380-4. doi: 10.1086/424883. Epub 2004 Oct 11.
10
Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.人类免疫缺陷病毒感染者中不伴有艾滋病定义的癌症的发病率及发病风险因素
Cancer. 2005 Oct 1;104(7):1505-11. doi: 10.1002/cncr.21334.

引用本文的文献

1
Changes in weight, body composition and metabolic parameters after switch to dolutegravir/lamivudine compared with continued treatment with dolutegravir/abacavir/lamivudine for virologically suppressed HIV infection (The AVERTAS trial): a randomised, open-label, superiority trial in Copenhagen, Denmark.在丹麦哥本哈根进行的一项随机、开放标签、优效性试验(AVERTAS 试验)中,与继续使用多替拉韦/阿巴卡韦/拉米夫定治疗相比,转换为多替拉韦/拉米夫定治疗对病毒学抑制的 HIV 感染患者的体重、身体成分和代谢参数的变化。
BMJ Open. 2023 Aug 21;13(8):e075673. doi: 10.1136/bmjopen-2023-075673.
2
Evaluation of antiretroviral therapy effect and prognosis between HIV-1 recent and long-term infection based on a rapid recent infection testing algorithm.基于快速近期感染检测算法评估HIV-1近期感染与长期感染患者的抗逆转录病毒治疗效果及预后
Front Microbiol. 2022 Nov 22;13:1004960. doi: 10.3389/fmicb.2022.1004960. eCollection 2022.
3
The burden of serious non-AIDS-defining events among admitted cART-naive AIDS patients in China: An observational cohort study.中国接受抗逆转录病毒治疗(cART)初治艾滋病患者中严重非艾滋病定义性疾病的负担:一项观察性队列研究。
PLoS One. 2020 Dec 22;15(12):e0243773. doi: 10.1371/journal.pone.0243773. eCollection 2020.
4
Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study.慢性丙型肝炎病毒感染者罹患动脉粥样硬化性心血管疾病的全球负担:系统评价、荟萃分析和模型研究。
Lancet Gastroenterol Hepatol. 2019 Oct;4(10):794-804. doi: 10.1016/S2468-1253(19)30227-4. Epub 2019 Jul 31.
5
Outcomes and factors influencing outcomes of critically ill HIV-positive patients in a tertiary care center in South India.印度南部一家三级护理中心重症HIV阳性患者的治疗结果及影响治疗结果的因素。
J Family Med Prim Care. 2019 Jan;8(1):97-101. doi: 10.4103/jfmpc.jfmpc_156_18.
6
Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studies.与 HIV 感染者接触阿巴卡韦相关的心血管疾病风险:来自 17 项流行病学研究结果的系统评价和荟萃分析。
Int J Antimicrob Agents. 2018 Nov;52(5):541-553. doi: 10.1016/j.ijantimicag.2018.07.010. Epub 2018 Jul 21.
7
Highly active antiretroviral therapy for critically ill HIV patients: A systematic review and meta-analysis.针对重症HIV患者的高效抗逆转录病毒治疗:一项系统评价与荟萃分析。
PLoS One. 2017 Oct 24;12(10):e0186968. doi: 10.1371/journal.pone.0186968. eCollection 2017.
8
Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals.循环 miR-122 和 miR-200a 作为抗逆转录病毒治疗、HIV-1 感染个体致命肝病的生物标志物。
Sci Rep. 2017 Sep 7;7(1):10934. doi: 10.1038/s41598-017-11405-8.
9
A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy.拉丁美洲十年高效抗逆转录病毒治疗:首批接受联合治疗的艾滋病患者的长期治疗结果
PLoS One. 2017 Jun 26;12(6):e0179769. doi: 10.1371/journal.pone.0179769. eCollection 2017.
10
Liver involvement in human immunodeficiency virus infection.肝脏与人类免疫缺陷病毒感染
Indian J Gastroenterol. 2016 Jul;35(4):260-73. doi: 10.1007/s12664-016-0666-8. Epub 2016 Jun 3.